Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03256344
Title Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | CHE | BEL | AUS

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90095 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Stony Brook University Stony Brook New York 11794-9446 United States Details
Liverpool Hospital Liverpool New South Wales 2170 Australia Details
Monash Medical Centre Clayton Victoria 3168 Australia Details
Fiona Stanley Hospital Murdoch Western Australia 6150 Australia Details
Breast Cancer Research Centre - WA Nedlands Western Australia 6009 Australia Details
Universite Catholique de Louvain Cliniques Universitaires Saint Luc Bruxelles 1200 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Charite Universitätsmedizin Berlin, Charité Campus Virchow-Klinikum Berlin 13353 Germany Details
Universitätsklinikum Bonn Bonn 53105 Germany Details
Universitätsklinik Tübingen Tübingen 72076 Germany Details
Hospital del Mar Barcelona Cataluña 08003 Spain Details
Hospital General Universitario Gregorio Marañon Madrid 28007 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
Inselspital Bern Bern 3010 Switzerland Details
Hopitaux Universitaires de Geneve Geneva 14 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field